Archer Investment Corporation’s Takeda Pharmaceutical TAK Stock Holding History

Archer Investment Corporation’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.36K	Hold	147	–	–	﹤0.01%	1030
2026 Q1	$2.72K	Hold	147	–	–	﹤0.01%	1022
2025 Q4	$2.29K	Sell	147 -150	-51%	-$2.15K	﹤0.01%	973
2025 Q3	$4.35K	Hold	297	–	–	﹤0.01%	890
2025 Q2	$4.59K	Hold	297	–	–	﹤0.01%	855
2025 Q1	$4.42K	Hold	297	–	–	﹤0.01%	838
2024 Q4	$3.93K	Hold	297	–	–	﹤0.01%	851
2024 Q3	$4.22K	Hold	297	–	–	﹤0.01%	831
2024 Q2	$3.84K	Hold	297	–	–	﹤0.01%	818
2024 Q1	$4.13K	Hold	297	–	–	﹤0.01%	797
2023 Q4	$4.24K	Hold	297	–	–	﹤0.01%	804
2023 Q3	$4.59K	Hold	297	–	–	﹤0.01%	765
2023 Q2	$4.67K	Hold	297	–	–	﹤0.01%	750
2023 Q1	$4.89K	Hold	297	–	–	﹤0.01%	659
2022 Q4	$4.63K	Hold	297	–	–	﹤0.01%	640
2022 Q3	$3.85K	Hold	297	–	–	﹤0.01%	628
2022 Q2	$4.17K	Hold	297	–	–	﹤0.01%	628
2022 Q1	$4.25K	Sell	297 -297	-50%	-$4.36K	﹤0.01%	634
2021 Q4	$8.91K	Buy	594 +297	+100%	+$4.17K	﹤0.01%	552
2021 Q3	$4.87K	Hold	297	–	–	﹤0.01%	596
2021 Q2	$5K	Sell	297 -35	-11%	-$596	﹤0.01%	496
2021 Q1	$6.06K	Hold	332	–	–	﹤0.01%	589
2020 Q4	$6.04K	Hold	332	–	–	﹤0.01%	543
2020 Q3	$5.92K	Sell	332 -221	-40%	-$4.02K	﹤0.01%	490
2020 Q2	$9.91K	Hold	553	–	–	0.01%	435
2020 Q1	$8K	Hold	553	–	–	0.01%	444
2019 Q4	$11K	Hold	553	–	–	0.01%	445
2019 Q3	$10K	Buy	553 +297	+116%	+$5.14K	0.01%	347
2019 Q2	$5K	Hold	256	–	–	﹤0.01%	388
2019 Q1	$5K	Buy	+256	New	+$5.15K	﹤0.01%	391

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

MAP

Managed Asset Portfolios Rochester, Michigan $875M AUM 41.9% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Archer Investment Corporation's TAK Position: Q2 2026 in Review

Archer Investment Corporation held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 147 shares worth $2.36K. The position accounts for ﹤0.01% of the portfolio, ranked #1030.

Archer Investment Corporation first reported a position in TAK in Q1 2019 and has held it in 30 quarters since. The position peaked at $11K in Q4 2019. 265 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Archer Investment Corporation held 147 shares of Takeda Pharmaceutical worth $2.36K as of Q2 2026.
Archer Investment Corporation left its Takeda Pharmaceutical share count unchanged in Q2 2026.
Takeda Pharmaceutical made up ﹤0.01% of Archer Investment Corporation's portfolio in Q2 2026, its #1030 holding.
Archer Investment Corporation first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 30 quarters since.
Archer Investment Corporation's Takeda Pharmaceutical position peaked at $11K in Q4 2019.
265 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Archer Investment Corporation's 13F filing for Q2 2026, filed 3 Aug 2026.